Literature DB >> 28950145

Determination of poor prognostic immune features of tumour microenvironment in non-smoking patients with lung adenocarcinoma.

Tomonari Kinoshita1, Chie Kudo-Saito2, Reiko Muramatsu3, Tomonobu Fujita3, Miyuki Saito3, Haruna Nagumo3, Toshiharu Sakurai3, Shinobu Noji3, Emi Takahata3, Tomonori Yaguchi3, Nobuo Tsukamoto3, Yuichiro Hayashi4, Kaoru Kaseda5, Ikuo Kamiyama5, Takashi Ohtsuka5, Kenji Tomizawa6, Masaki Shimoji6, Tetsuya Mitsudomi6, Hisao Asamura5, Yutaka Kawakami7.   

Abstract

We have previously demonstrated that the prognostic significance of tumour-infiltrating CD8+ T cells significantly differs according to histological type and patient smoking habits in non-small cell lung cancer (NSCLC). This work suggested that infiltrating CD8+ T cells may not be activated sufficiently in the immunosuppressive microenvironment in non-smokers with adenocarcinoma. To understand the immunogenic microenvironment in NSCLC, we characterised immune cells comprehensively by performing an immunohistochemical evaluation using an alternative counting method and multicolour staining method (n = 234), and assessed immune-related gene expression by using genetic analytical approaches (n = 58). We found that high infiltration of activated CD8+ T cells expressing interferon gamma (IFN-γ) and granzyme was correlated with postoperative survival in patients with non-adenocarcinoma. On the contrary, CD8+ T-cell accumulation was identified as a worse prognostic factor in patients with adenocarcinoma, particularly in non-smokers. Infiltrating CD8+ T cells were significantly less activated in this microenvironment with high expression of various immunoregulation genes. Potentially immunoregulatory CD8+ FOXP3+ T cells and immunodysfunctional CD8+ GATA3+ T cells were increased in adenocarcinoma of non-smokers. CD4+ FOXP3+ regulatory T cells expressing chemokine receptor-4 (CCR4)- and chemokine ligand (CCL17)-expressing CD163+ M2-like macrophages also accumulated correlatively and significantly in adenocarcinoma of non-smokers. These characteristic immune cells may promote tumour progression possibly by creating an immunosuppressive microenvironment in non-smoking patients with lung adenocarcinoma. Our findings may be helpful for refining the current strategy of personalised immunotherapy including immune-checkpoint blockade therapy for NSCLC.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adenocarcinoma; Immunosuppression; Non-small cell lung cancer; Smoking history; Tumour microenvironment

Mesh:

Substances:

Year:  2017        PMID: 28950145     DOI: 10.1016/j.ejca.2017.08.026

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  28 in total

1.  Tumor microenvironment as a potential source of clinical biomarkers in non-small cell lung cancer: can we use enemy territory at our advantage?

Authors:  Carlo Genova; Erika Rijavec; Francesco Grossi
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

2.  KDM5A regulates the growth and gefitinib drug resistance against human lung adenocarcinoma cells.

Authors:  Hong Wu; Lidong Xu; Xun Hu
Journal:  3 Biotech       Date:  2022-03-19       Impact factor: 2.406

3.  Interface of cancer stem cells and cancer immunity.

Authors:  Tomonari Kinoshita; Yutaka Kawakami
Journal:  Ann Transl Med       Date:  2020-07

Review 4.  Lung cancer in never smokers-the East Asian experience.

Authors:  Fei Zhou; Caicun Zhou
Journal:  Transl Lung Cancer Res       Date:  2018-08

5.  Comprehensive genomic and immunophenotypic analysis of CD4 T cell infiltrating human triple-negative breast cancer.

Authors:  He Zhang; Guohui Qin; Hui Yu; Xu Han; Sha Zhu
Journal:  Cancer Immunol Immunother       Date:  2020-12-10       Impact factor: 6.968

Review 6.  Non-Canonical Thinking for Targeting ALK-Fusion Onco-Proteins in Lung Cancer.

Authors:  Wei Wu; Franziska Haderk; Trever G Bivona
Journal:  Cancers (Basel)       Date:  2017-11-30       Impact factor: 6.639

7.  Chromogenic Multiplex Immunohistochemistry Reveals Modulation of the Immune Microenvironment Associated with Survival in Elderly Patients with Lung Adenocarcinoma.

Authors:  Marius Ilié; Mélanie Beaulande; Saima Ben Hadj; Emmanuel Chamorey; Renaud Schiappa; Elodie Long-Mira; Sandra Lassalle; Catherine Butori; Charlotte Cohen; Sylvie Leroy; Olivier Guérin; Jérôme Mouroux; Charles-Hugo Marquette; Jean-François Pomerol; Gilles Erb; Véronique Hofman; Paul Hofman
Journal:  Cancers (Basel)       Date:  2018-09-13       Impact factor: 6.639

8.  CSF1R-Expressing Tumor-Associated Macrophages, Smoking and Survival in Lung Adenocarcinoma: Analyses Using Quantitative Phosphor-Integrated Dot Staining.

Authors:  Kentaro Inamura; Yasuyuki Shigematsu; Hironori Ninomiya; Yasuhiro Nakashima; Maki Kobayashi; Haruyuki Saito; Katsuhiro Takahashi; Etsuko Futaya; Sakae Okumura; Yuichi Ishikawa; Hiroaki Kanda
Journal:  Cancers (Basel)       Date:  2018-07-31       Impact factor: 6.639

9.  Tumor infiltrating T cells influence prognosis in stage I-III non-small cell lung cancer.

Authors:  Arik Bernard Schulze; Georg Evers; Dennis Görlich; Michael Mohr; Alessandro Marra; Ludger Hillejan; Jan Rehkämper; Lars Henning Schmidt; Birthe Heitkötter
Journal:  J Thorac Dis       Date:  2020-05       Impact factor: 3.005

10.  Immune microenvironment composition in non-small cell lung cancer and its association with survival.

Authors:  Menno Tamminga; Thijo Jeroen N Hiltermann; Ed Schuuring; Wim Timens; Rudolf Sn Fehrmann; Harry Jm Groen
Journal:  Clin Transl Immunology       Date:  2020-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.